Prognostic Factors in the Surgical Management of Pericardial Effusion in the Patient With Concurrent Malignancy

Pericardiocentesis versus Pericardiotomy for Malignant Pericardial Effusion: A Retrospective Comparison

“…The yields with both techniques were very low in the latter study; hence, the diagnostic yield of 86.7% that we observed seems more accurate. Finally, the median survival of 2.5 months with both techniques is comparable to that in previous reports 4 .…”

“…Malignancies can involve the pericardium by four mechanisms: direct extension or metastatic spread via lymphatics or blood, chemotherapeutic toxicity, radiation toxicity, and opportunistic infections related to immunosuppressive therapies 3 . Despite treatment, median overall survival in patients with malignant pericardial effusion is reported to be in the range of 2-4 months and is influenced mainly by the nature of the underlying malignancy, lung cancer being a poor prognostic factor 4 .…”

The efficacy of VATS, subxiphoid and minithoracotomy pericardial window for surgical management of symptomatic pericardial effusions

“…Bu üç cerrahi yöntemi aynı çalışmada değer-lendiren oldukça sınırlı sayıda çalışma vardır [5][6][7][8][9].…”

“…Piehler ve ark. ise, biyopsi de elde edilen perikard dokusu ile tanı ve nüks arasında doğru orantı olduğunu, bu nedenle perikardiektomi yapılmasını önermiştir [7]. Çalışmamızda grup 3'te 9 (%69,9) kanser hastasında önceden perikardiyosentez yapılmış ancak sitopatolojik incelemelerde maligniteye rastlanmamış ve biyopsi ile malignite tanısı konmuştu.…”

Manejo del derrame pericárdico en el paciente con cáncer

“…Actualmente, en los centros de referencia, el derrame pericárdico maligno sigue siendo la complicación cardiaca más frecuente, aunque con una incidencia menor de 1 a 10 %. Con la adecuada evacuación del derrame pericárdico, la supervivencia global aumenta a 28 semanas y puede ser superior, hasta 20 años, cuando no hay recurrencia del derrame pericárdico y según los factores pronósticos del paciente 3,4 .…”